Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Marquez-Rodas I, Dutriaux C, Saiag P, de la Cruz Merino L, Castanon Alvarez E, Robert C, Rodriguez-Moreno JF, Arance A, Cerezuela-Fuentes P, Montaudie H, Sanmamed MF, Gonzalez-Cao M, Charles J, Lopez Criado MP, Berrocal A, de Miguel E, Funck-Brentano E, Prey S, Alamo de la Gala MC, Melero I, Aviles-Izquierdo JA, Roman R, Garcia-Pelaez B, Rodriguez S, Trnkova ZJ, Quintero M, Macia S, Chaney MF, Dalle S. BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203. J Clin Oncol. 2025 Jun 27:JCO2402595. doi: 10.1200/JCO-24-02595. Online ahead of print. PubMed PMID: 40577656.
AÑO: 2025; IF: 42.1
40577656
de Bono JS, Williams A, Melero I, Jayaram A, Hawley JE, Doger de Speville B, Moreno I, Castellano D, Reig O, Knapen DG, Anguera G, Martinez J, Gort E, de Jonge M, Alonso-Romero JL, Boni V, Perez-Gracia JL, Falcon A, de Groot DJ, Pierce AJ, Leishman AJ, Lloyd P, Bartlett PD, Bland-Ward P, Chau A, Song M, Duffy K, Hashimoto K, de Vries E. A phase I dose escalation and cohort expansion study of CB307, a trispecific Humabody(R) against PSMA, CD137, and albumin in patients with PSMA-positive solid tumors. Clin Cancer Res. 2025 Mar 17. doi: 10.1158/1078-0432.CCR-24-3581. Online ahead of print. PubMed PMID: 40094417.
AÑO: 2025; IF: 10.0
40094417
Royo-Villanova M, Minambres E, Sanchez JM, Torres E, Manso C, Ballesteros MA, Parrilla G, de Paco Tudela G, Coll E, Perez-Blanco A, Dominguez-Gil B. Maintaining the permanence principle of death during normothermic regional perfusion in controlled donation after the circulatory determination of death: Results of a prospective clinical study. Am J Transplant. 2024 Feb;24(2):213-221. doi: 10.1016/j.ajt.2023.09.008. Epub 2023 Sep 20. PubMed PMID: 37739346.
AÑO: 2024; IF: 8.9
37739346
Li X, Zhang Y, Zhu C, Xu W, Hu X, Martinez DAS, Romero JLA, Yan M, Dai Y, Wang H. Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer. BMC Womens Health. 2024 Jan 13;24(1):38. doi: 10.1186/s12905-023-02871-6. PubMed PMID: 38218823; PubMed Central PMCID: PMC10787989.
AÑO: 2024; IF: 2.4
38218823
Llombart-Cussac A, Perez-Garcia JM, Ruiz Borrego M, Tolosa P, Blanch S, Fernandez-Ortega A, Urruticoechea A, Blancas I, Saura C, Rojas B, Bermejo B, Ponce Lorenzo J, Gion M, Cortez-Castedo P, Llabres E, Galve E, Cueva JF, Lopez A, Alonso-Romero JL, Gonzalez-Santiago S, Martinez de Duenas E, Ciruelos E, Martrat G, Gener P, Alcala-Lopez D, Sampayo-Cordero M, Gomez-Peralta F, Cortes J. Preventing alpelisib-related hyperglycaemia in HR+/HER2-/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial. EClinicalMedicine. 2024 Apr 11;71:102520. doi: 10.1016/j.eclinm.2024.102520. eCollection 2024 May. PubMed PMID: 38638399; PubMed Central PMCID: PMC11024566.
AÑO: 2024; IF: 9.6
38638399
Siguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

ONCOLOGÍA CLÍNICA Y TRASLACIONAL